Media

Algernon Pharmaceuticals updates Phase 2 human testing of Ifenprodil for COVID-19
Equity Insight – Interview with CEO of Algernon Pharmaceuticals
WEBCAST: BioPub.co Presents: Algernon Pharmaceuticals (CSE: AGN   OTCQB: AGNPF)